Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation.
about
Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantationGenes, tolerance and systemic autoimmunityHuman T regulatory cell therapy: take a billion or so and call me in the morningHIV infection of naturally occurring and genetically reprogrammed human regulatory T-cellsAutoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell TherapyThymic and Postthymic Regulation of Naïve CD4(+) T-Cell Lineage Fates in Humans and Mice ModelsTherapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic StrategiesNK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell EngraftmentApplication of IL-2 therapy to target T regulatory cell functionNew allogeneic hematopoietic stem cell transplantation method: hematopoietic stem cell transplantation plus thymus transplantation for intractable diseasesDistinct effects of IL-18 on the engraftment and function of human effector CD8 T cells and regulatory T cellsAcute graft-versus-host disease: a bench-to-bedside update.The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical OverviewGenetic barriers in transplantation medicineFriend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphomaHaploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular TherapyRetinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cellsProline-rich motifs of the Na+/H+ exchanger 2 isoform. Binding of Src homology domain 3 and role in apical targeting in epithelia.CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy-treated hemophilia mice.Intravital imaging of donor allogeneic effector and regulatory T cells with host dendritic cells during GVHD.Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapyClinical grade Treg: GMP isolation, improvement of purity by CD127 Depletion, Treg expansion, and Treg cryopreservationSuppression of glomerulonephritis in NZB/NZW lupus prone mice by adoptive transfer of ex vivo expanded regulatory T cells.Manipulating IL-2 availability amid presentation of donor MHC antigens suppresses murine alloimmune responses by inducing regulatory T cells.Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1.The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host diseaseEndothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemiaSuppression of allograft rejection by CD8+CD122+PD-1+ Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis.Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.Granzyme B is not required for regulatory T cell-mediated suppression of graft-versus-host disease.Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells.Transplantation of Donor-Origin Mouse Embryonic Stem Cell-Derived Thymic Epithelial Progenitors Prevents the Development of Chronic Graft-versus-Host Disease in Mice.Allogeneic T regulatory cell-mediated transplantation tolerance in adoptive therapy depends on dominant peripheral suppression and central tolerance.Path to clinical transplantation tolerance and prevention of graft-versus-host disease.Can antigen-specific regulatory T cells protect against graft versus host disease and spare anti-malignancy alloresponse?A reduction of recipient regulatory T cells by cyclophosphamide contributes to an anti-tumor effect of nonmyeloablative allogeneic stem cell transplantation in mice.Hematopoietic progenitor cell regulation by CD4+CD25+ T cells.Reconstitution of self-tolerance after hematopoietic stem cell transplantationCCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease.
P2860
Q21132345-F6B49279-51B5-4AFD-8205-AE4223B93A88Q24615454-11D870C6-7B3D-4C7D-B938-FF7A6D8C345FQ24656069-2C2AB2D9-A828-4B5F-A9BB-E0468A1F1AC6Q24802813-EC80140D-A8CE-4464-A3A0-3E5B457F4CC8Q26742101-C2E3881D-B10A-42B3-97D9-EBC32D8E3365Q26745612-C19E7694-F47D-4696-87FD-8C76ACE5E6DCQ26751959-09A65CA9-7245-4D67-8597-3D2E3A4A86EFQ26765845-D9D362DE-ECAB-491D-8256-1A93D45BB572Q26827327-A5BEA8D7-1FD8-41D3-9A9B-165B3260C8C0Q26996496-A893BD8E-CBC0-486B-9E96-D913E9173AEDQ27438176-E5E97E30-BAB3-474B-A978-6E5543ED0F8EQ27687130-5AA581FE-7C1A-403F-BEB7-69E86ECBEA2DQ28066083-A91D3659-3E1A-438A-9466-28EB0B198DE4Q28069956-5C21CE7B-7376-4BEB-ADAE-FEB53B080F79Q28072320-05B6F9C3-6F87-403F-89F1-1477130A7D54Q28085397-A0E50D24-9796-41ED-B7B5-DCEF10DD1FCEQ28743652-F5A0C4EA-081F-4C58-A361-FF4E6A99B6CAQ30175804-D3A8EBF0-A5E8-460A-AB71-EB4F5D3A674FQ30491507-9C25941B-3B05-47AF-90E4-F52AE9B53A7AQ30573584-030D0126-FC89-4947-A5E1-1E6712375AF8Q33336577-3982B378-7F7F-4971-B020-3ACA8DDC5350Q33367565-A14FB829-AD3E-4B93-B8A6-D7F6FE00CA95Q33473900-9E9F9452-C39C-4643-95BE-66844651E794Q33525541-5600521E-B73A-49E6-BAC7-B7FB3F8E9C64Q33528964-3C72E916-34E0-4FA7-BF3A-0A86B5DE359EQ33559627-67757EE6-0463-4D19-ADE1-8CE4F1AA3568Q33618681-7A6BE014-39A0-479F-B335-B9F0288A223BQ33629928-CCC10DE0-56D3-4512-B5B3-6B212AA5CBBBQ33648417-1B6CF31A-20F6-420A-8A26-29D397F12D99Q33685495-995981B6-289C-43D0-9B13-3B3AFC66008AQ33706382-36CCE07C-B1D7-4C48-A29A-2801578A167CQ33715925-52A9D9BE-6AFA-439F-9B11-DB07B1FA5D87Q33722135-AE4A25F3-77DC-4E61-A986-C81E5A732E3DQ33722667-9370627A-D93E-44DE-B756-7CC716D1D4DBQ33734003-BC42A66F-19C6-4397-ADB5-AC6C783063E1Q33800533-A111C2F3-3357-480C-8B12-F1AFBD3559C1Q33829731-0909C2C2-4D4E-4DCF-A202-49086671E017Q33931910-E39FD6B9-CCCF-4CBF-BA2C-22C88D9100E6Q33945960-81B94008-B169-41E2-926B-9475F2BE266AQ33980867-F145CF2B-BC01-4043-BA63-BF7BAA680322
P2860
Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Donor-type CD4(+)CD25(+) regul ...... c bone marrow transplantation.
@ast
Donor-type CD4(+)CD25(+) regul ...... c bone marrow transplantation.
@en
type
label
Donor-type CD4(+)CD25(+) regul ...... c bone marrow transplantation.
@ast
Donor-type CD4(+)CD25(+) regul ...... c bone marrow transplantation.
@en
prefLabel
Donor-type CD4(+)CD25(+) regul ...... c bone marrow transplantation.
@ast
Donor-type CD4(+)CD25(+) regul ...... c bone marrow transplantation.
@en
P2093
P2860
P356
P1476
Donor-type CD4(+)CD25(+) regul ...... c bone marrow transplantation.
@en
P2093
C Garrison Fathman
Joerg Ermann
Matthias Edinger
Petra Hoffmann
Samuel Strober
P2860
P304
P356
10.1084/JEM.20020399
P407
P577
2002-08-01T00:00:00Z